Avalon’s mission is to accelerate the development of a cure for ageing. Neuro-degenerative diseases like Alzheimer’s are extremely terrifying, robbing people of their identity and dignity. Yet, as our population ages, a third of us will end our lives with some such condition. Avalon is using machine learning to automatically derive accurate brain features (e.g. the volume of the hippocampus) from brain scans and compare them to a normative population. It also provides handy 2D and 3D visualisations of brain features, which help neuro-radiologists make highly accurate reports and diagnoses.
How they’re disrupting
Avalon is building the world’s smartest brain degeneration predictor. It is applying its deep learning diagnosis tools to data derived from MRI scans to maximise the accuracy of brain degeneration predictions.
More than 46 million people live with dementia worldwide, more than the total population of Spain. By 2050, this number will have increased to an estimated 131.5 million people.
Investments and future
No investment data is available. Avalon AI is currently running trials with select clinics in India, Pakistan and Ukraine.